Covid Safe Ticket (3G vs 2G or 1G) and mandatory vaccination in the context of the COVID-19 pandemic and Omicron
In this STATE OF KNOWLEDGE AND POSITION PAPER, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides some partial answers about the efficacy of the Covid Safe Ticket (3G [vaccinated, tested or cured], as currently applied in Belgium, vs 2G or 1G) and mandatory vaccination on the immunization coverage in the context of the COVID-19 pandemic and Omicron.
The Superior Health Council was invited to present this report at the Committee on Health and Equal Opportunities of the House of Representatives on Friday February 4th. The viewing can be accessed online via http://www.lachambre.be/media/index.html?sid=55U2508. The presentation is available at https://www.health.belgium.be/en/4-february-2022-chamber-representatives.
-
Prise de position 9689 - CST et vaccination obligatoire contre la COVID-19
Français20220223_css-9689_cst-vaccination_obligatoire_vweb.pdf PDF document - 5.01 Mo
-
Positienota 9689 - CST en verplichte vaccinatie tegen COVID-19
Néerlandais20220223_hgr-9689_cst-vaccinatieplicht_vweb.pdf PDF document - 5.87 Mo
-
Position paper 9689 - CST and mandatory vaccination against COVID-19
Anglais20220203_shc-9689_cst-mandatory_vaccination_vweb.pdf PDF document - 5.34 Mo
-
Positionspapier 9689 - CST und Impfpflicht gegen COVID-19
Allemand20220228_hgr-9689_cst-impfpflicht_vweb.pdf PDF document - 5.83 Mo